IUSDF logo

AS ONE Corporation (IUSDF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, AS ONE Corporation (IUSDF) es una empresa del sector Healthcare valorada en 0. Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 46/100

AS ONE Corporation (IUSDF) Resumen de Asistencia Médica y Tuberías

Empleados731
Sede CentralOsaka, Japan

AS ONE Corporation, founded in 1933 and headquartered in Osaka, Japan, distributes a comprehensive range of research instruments, equipment, and healthcare products. Operating both domestically and internationally, the company serves scientific, industrial, and healthcare sectors, providing essential tools and supplies with a focus on quality and reliability.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

AS ONE Corporation presents a stable investment profile within the medical distribution sector, supported by a diversified product range and established market presence. With a market capitalization of $1.00 billion and a healthy profit margin of 8.3%, the company demonstrates financial stability. A return on equity (ROE) of 13.5% indicates efficient utilization of shareholder equity. The company's beta of 0.63 suggests lower volatility compared to the broader market. Growth catalysts include expanding its product offerings and penetrating new geographic markets. Potential risks include increased competition and fluctuations in currency exchange rates. The company's strong gross margin of 30.4% provides a buffer against cost pressures.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market Cap of $1.00 billion indicates a solid valuation in the medical distribution sector.
  • Profit Margin of 8.3% reflects efficient operations and profitability.
  • Gross Margin of 30.4% demonstrates the company's ability to manage production costs effectively.
  • Return on Equity (ROE) of 13.5% shows efficient utilization of shareholder equity.
  • Debt-to-Equity Ratio of 7.84 indicates a relatively leveraged capital structure.

Competidores y Pares

Fortalezas

  • Diversified product portfolio.
  • Established distribution network.
  • Strong brand reputation.
  • Presence in multiple sectors (scientific, industrial, healthcare).

Debilidades

  • High debt-to-equity ratio.
  • Dependence on suppliers.
  • Limited proprietary products.
  • Exposure to currency exchange rate fluctuations.

Catalizadores

  • Upcoming: Potential expansion into new geographic markets in Asia and Latin America.
  • Ongoing: Development of proprietary products and services to enhance competitive advantage.
  • Ongoing: Leveraging e-commerce and digital marketing to improve reach and efficiency.

Riesgos

  • Potential: Increased competition from larger medical distributors.
  • Potential: Regulatory changes affecting the medical device industry.
  • Potential: Economic downturns impacting healthcare spending.
  • Ongoing: High debt-to-equity ratio increasing financial risk.
  • Ongoing: Exposure to currency exchange rate fluctuations.

Oportunidades de crecimiento

  • Expansion into New Therapeutic Areas: AS ONE can capitalize on the growing demand for specialized medical equipment and supplies by expanding its product offerings in emerging therapeutic areas such as gene therapy and personalized medicine. The global market for gene therapy is projected to reach $25 billion by 2028, presenting a significant growth opportunity. By partnering with innovative biotech companies and research institutions, AS ONE can gain access to cutting-edge technologies and establish a strong foothold in these high-growth markets.
  • Geographic Expansion into Emerging Markets: AS ONE can drive growth by expanding its operations into emerging markets in Asia and Latin America, where healthcare spending is rapidly increasing. These regions offer significant opportunities for medical distributors due to growing populations and increasing access to healthcare services. By establishing local distribution networks and tailoring its product offerings to meet the specific needs of these markets, AS ONE can capture a significant share of the growing demand for medical equipment and supplies.
  • Strategic Acquisitions of Complementary Businesses: AS ONE can accelerate its growth by acquiring complementary businesses in the medical distribution sector. This includes companies with specialized product lines, established customer relationships, or unique technological capabilities. Strategic acquisitions can help AS ONE expand its product portfolio, strengthen its market position, and gain access to new geographic markets. The company can focus on acquiring businesses that align with its core competencies and strategic objectives.
  • Development of Proprietary Products and Services: AS ONE can enhance its competitive advantage by developing proprietary products and services that address unmet needs in the medical and scientific communities. This includes developing innovative laboratory equipment, diagnostic tools, and healthcare solutions. By investing in research and development and collaborating with leading scientists and clinicians, AS ONE can create differentiated products that command premium pricing and generate higher margins. The company can also offer value-added services such as equipment maintenance, training, and consulting to further enhance its customer relationships.
  • Leveraging E-commerce and Digital Marketing: AS ONE can improve its reach and efficiency by leveraging e-commerce and digital marketing channels. This includes developing a user-friendly online platform for customers to browse and purchase products, as well as implementing targeted digital marketing campaigns to reach new customers and promote its product offerings. By embracing digital technologies, AS ONE can reduce its operating costs, improve its customer service, and expand its market reach. The global e-commerce market for medical equipment and supplies is projected to reach $50 billion by 2027, presenting a significant growth opportunity for AS ONE.

Oportunidades

  • Expansion into new geographic markets.
  • Development of proprietary products.
  • Strategic acquisitions of complementary businesses.
  • Leveraging e-commerce and digital marketing.

Amenazas

  • Increased competition.
  • Regulatory changes.
  • Economic downturns.
  • Disruptive technologies.

Ventajas competitivas

  • Established distribution network in Japan and internationally.
  • Diversified product portfolio across multiple sectors.
  • Long-standing relationships with suppliers and customers.
  • Reputation for quality and reliability.

Acerca de IUSDF

Founded in 1933, AS ONE Corporation has evolved into a key distributor of research instruments, equipment, and healthcare products. Headquartered in Osaka, Japan, the company serves a diverse range of sectors, including scientific research, industrial manufacturing, and healthcare. Its product portfolio includes scientific instruments such as temperature and humidity control devices, microscopes, and laboratory equipment. For the industrial sector, AS ONE offers dehumidifying storage products, sterilization equipment, and cleanroom supplies. In the healthcare sector, the company provides hospital and nursing instruments, including gowns, masks, gloves, and care equipment. AS ONE Corporation operates both domestically within Japan and internationally, ensuring a broad market reach. The company's commitment to quality and reliability has established it as a trusted supplier in its core markets. AS ONE's extensive product range and established distribution network allow it to cater to a wide array of customer needs, from basic laboratory supplies to specialized equipment for advanced research and healthcare applications.

Qué hacen

  • Distributes research instruments and equipment.
  • Offers nursing and care products for hospitals and healthcare facilities.
  • Provides scientific instruments for temperature and humidity control.
  • Supplies microscopes, glass slides, and tissue culture products for biotechnology.
  • Offers industrial instruments for dehumidifying storage and sterilization.
  • Provides cleanroom supplies, including clothing and mats.
  • Distributes hospital/nursing instruments, such as gowns, masks, and gloves.

Modelo de Negocio

  • Distributes a wide range of products across multiple sectors (scientific, industrial, healthcare).
  • Generates revenue through the sale of products to end-users and institutions.
  • Maintains a distribution network in Japan and internationally.

Contexto de la Industria

AS ONE Corporation operates within the medical distribution industry, which is characterized by steady growth driven by increasing healthcare spending and advancements in medical technology. The market is competitive, with numerous players ranging from large multinational corporations to smaller regional distributors. AS ONE distinguishes itself through its comprehensive product range and established presence in both the scientific and healthcare sectors. The industry is influenced by factors such as regulatory changes, technological innovation, and economic conditions. AS ONE's diversified product portfolio helps mitigate risks associated with specific market segments.

Clientes Clave

  • Research institutions and laboratories.
  • Hospitals and healthcare facilities.
  • Industrial manufacturers.
  • Universities and educational institutions.
Confianza de la IA: 71% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de AS ONE Corporation (IUSDF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para IUSDF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para IUSDF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para IUSDF.

MoonshotScore

46/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de IUSDF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Información del mercado OTC de IUSDF

The OTC Other tier represents the lowest tier of the OTC market, indicating that AS ONE Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more challenging for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for less transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: As an OTC stock, IUSDF's liquidity may be limited, resulting in wider bid-ask spreads and potential difficulty in executing large trades without significantly impacting the price. Investors should be prepared for potentially lower trading volumes compared to stocks listed on major exchanges. This can make it more challenging to enter or exit positions quickly, especially for larger investors.
Factores de riesgo OTC:
  • Limited financial disclosure due to OTC Other tier status.
  • Lower liquidity compared to major exchanges.
  • Potential for wider bid-ask spreads.
  • Higher degree of regulatory scrutiny.
  • Increased risk of fraud or manipulation.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's competitive landscape and market position.
  • Evaluate the company's business model and revenue streams.
  • Check for any legal or regulatory issues.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor.
Señales de legitimidad:
  • Established operating history since 1933.
  • Presence in multiple sectors (scientific, industrial, healthcare).
  • International operations in Japan and other countries.
  • Market capitalization of $1.00 billion.
  • Positive profit margin and return on equity.

Lo Que los Inversores Preguntan Sobre AS ONE Corporation (IUSDF)

¿Cuáles son los factores clave para evaluar IUSDF?

AS ONE Corporation (IUSDF) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Fortaleza clave: Diversified product portfolio.. Riesgo principal a monitorear: Potential: Increased competition from larger medical distributors.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de IUSDF?

IUSDF actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de IUSDF?

Los precios de IUSDF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre IUSDF?

La cobertura de analistas para IUSDF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en IUSDF?

Las categorías de riesgo para IUSDF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Increased competition from larger medical distributors.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de IUSDF?

La relación P/E para IUSDF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está IUSDF sobrevalorada o infravalorada?

Determinar si AS ONE Corporation (IUSDF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de IUSDF?

AS ONE Corporation (IUSDF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • AI analysis pending for IUSDF.
  • Limited information available on OTC disclosure status.
Fuentes de datos

Popular Stocks